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Abstract
Background: Several factors can interfere with the full physical and emotional growth of adolescents, among them
chronic diseases. The aim was to determine the nutritional status of adolescents and to associate it with puberty,
pancreatic sufficiency, lung function and age range of Cystic Fibrosis (CF) diagnosis.
Methods: An observational, cross-sectional, retrospective and analytical study was conducted using the data of
medical records. Setting: Reference center in the northeastern region of the state of São Paulo – Brazil. Patients: All
adolescents with CF attended in 2010 were included. Some variables included: pancreatic sufficiency (steatocrit >2 %),
pancreatic enzymes replacement (yes/no), pubertal status-Tanner criteria (prepubertal: M1/G1, pubertal:
M2/G2 to M4/G4, postpubertal: M5/G5), age at CF diagnosis (<2 and ≥2 years of age), Lung function, measured as a
predicted forced expiratory volume in 1 s (FEV1). Main outcome measures Nutritional indicators: body mass index for
age (BMI/A) and height for age (H/A) with z-score calculated with Anthro Plus software. Cut-off reference points: ≥ z-
score −3 and < z-score −2 (thinness); z-score −2 and ≤ z-score-z +1 (normal weight); >z-score +1 (overweight or
obesity), and z-score <−2 (low or very low H/A). The groups were compared by the Kruskal-Wallis test. Level of
significance: p < 0.05.
Results: Thirty adolescents. Median (min;max) age: 14.4 (10.1;19.8) years. BMI/A and H/A z-score, respectively: early
diagnosis of CF (−0.8; −1.1) or late diagnosis of CF (−0.5;-0.8); with pancreatic insufficiency (−0.7; −0.8) or without
pancreatic insufficiency (−0.8; −0.5) and prepubertal (−0.8; −0.7) pubertal (−0.2; −1.5) or postpubertal (−0.7; -0.5). No
significant difference (p > 0.05) was observed. Patients with and without pancreatic insufficiency, presented H/A
borderline z-score (p = 0.05). Association between H/A and FEV1 was borderline (p = 0.05).
Conclusions: Adolescents presented adequate nutritional status, although with slightly lower values than those of
developed countries. FEV1 lower levels occurred more frequently in adolescents with low H/A.
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Background
Adolescence is a phase of life developing from 10 to
19 years which is characterized by an evolving period with
marked body modifications and a high nutritional demand
and culminating with biopsychosocial maturation [1]. Rapid
linear growth, the pubertal spurt and sexual maturation
occur during this period and are evaluated according to the
different stages of the Tanner classification (M2 to M4 in
girls and G2 to G4 in boys) [2]. This second decade of life
is considered to be highly vulnerable since several factors
can interfere with the full physical and emotional growth of
adolescents, among them chronic diseases [3].
Cystic fibrosis (CF) is a lethal genetic disease of recessive
autosomal inheritance commonly affecting Caucasian
populations. CF is due to mutation of the Cystic Fibrosis
Transmembrane Conductance Regulator gene which in-
duces the production of thick and viscous secretions that
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obstruct the lungs, the pancreas and the bile duct. Among
various therapeutic measures, this disease requires the use
of pancreatic enzymes for patients with pancreatic insuffi-
ciency and a high-protein and high-calorie diet, which are
associated with better pulmonary function and longer sur-
vival [4].
Over the last few years, due to advances in the early
detection of the disease and to new treatments, the
prognosis of CF patients has improved, with an increase
in time and quality of life [5].
The objective of the present study was to determine
the nutritional status of adolescents seen at a reference
center and to associate it with the periods of puberty,
with pancreatic sufficiency, with pulmonary function
and with the age range of CF diagnosis.
Methods
An observational, cross-sectional, retrospective and ana-
lytical study was conducted using the data of medical
records of the Reference Center of Cystic Fibrosis of the
University Hospital. The city of Ribeirão Preto has a Hu-
man Development Index of 0.800 and serves a popula-
tion estimated at more than two million inhabitants
residing in the northeastern region of the state of São
Paulo. All adolescents treated in this service since its
creation, with a diagnosis of CF based on clinical mani-
festations and two sweat chloride tests >60 mEq/L, and
who had attended at least one medical visit in 2010 were
included in the study. There were 136 patients attended
in 2010 and 30 was adolescents. The sample size was 28
(IC 90 %), according with statcalc Epi-info seven, consid-
ering all patients attended and prevalence of 25 % of
undernutrition in infants and adolescents with cystic
fibrosis. However, we chose to work with convenience
sample. As there were no losses, all 30 teenagers partici-
pated in the study. The variables studied were age
(years), sex (M/F), reported color (white non-white),
weight (g), height (cm), pancreatic sufficiency defined
according to steatocrit >2 % and generating two sub-
groups, i.e., patients with pancreatic sufficiency (PS) and
patients with pancreatic insufficiency (PI), use of pancre-
atic enzymes (yes/no), use of nutritional supplement
(yes/no), chronic colonization to pseudomonas aerugi-
nosa (yes/no), cystic fibrosis related diabetes - CFRD
(yes/no), cystic fibrosis related hepatic disease - CFRHD.
Lung function (forced expiratory volume in 1 s, mea-
sured as a percent of predicted normal values - FEV1).
Biohumoral indirect parameters of patient’s nutritional
state levels: haemoglobin g/dL (Hb), total protein g/dL
(TP) and albumin g/dL. According to the Tanner cri-
teria, pubertal status was categorized as prepubertal
(M1/G1), pubertal (M2/G2 to M4/G4) and postpubertal
(M5/G5) and the age range at CF diagnosis was defined
as <2 and ≥2 years of age.
Anthropometric data such as weight and height were
used to determine the nutritional status. The anthropo-
metric indicators adopted were body mass index for age
(BMI/A) and height for age (H/A) according to chrono-
logical age and sex. BMI was calculated as weight (kg)
divided by height (m) squared. The z-score of the nutri-
tional indicators was calculated with the Anthro Plus soft-
ware using the cut-off reference points established by the
WHO [6]: ≥ z-score −3 and < z-score −2 (thinness); z-
score −2 and ≤ z-score-z +1 (normal weight); > z-score +1
(overweight or obesity), and z-score <−2 (low or very low
H/A). The groups were compared by univariate analysis
using the Kruskal-Wallis test of the EPI INFO 7 software,
with the level of significance set at p ≤ 0.05.
The study was approved by the Research Ethics Com-
mittee of the University Hospital Ribeirão Preto.
Results and discussion
The median (minimum; maximum) age of the 30 adoles-
cent patients followed up at the service was 14.4
(10.1;19.8) years; 53.4 % were males, 86.7 % were white,
70 % had PI, and 23.3 % were prepubertal, as shown in
Table 1.
FEV1 medians (min; max)was 78.5 (41.0; 111) and
82.5 (45.0;98.0) considering that diagnosed before and
after 2 years old, respectively (p > 0.05); 77.0 (45.0;102.0)
and 85.0 (41.0;111.0) to the PI and PS, respectively (p >
0.05) and yet 82.0 (51.0;97.0); 86.0 (66.0;92.0) and 71.5
(41.0;111.0) to prepubertal, pubertal and postpubertal
subgroups, respectively (p > 0.05).
FEV1 medians were 51.0 (51.0;51.0); 82.0 (41.0;111.0) e
88.0 (88.0;88.0) to thinness, normal weight and over-
weight or obesity (p > 0.05) and were 68.0 (45.0;88.0)
and 84.0 (41.0;111.0) to low height and normal height,
respectively (p = 0.05).
The FCDR was present in 13.3 % (4/30) and the FCDR
in 26.7 % (8/30) of the adolescents.
BMI/A medians (min; max) was −0.64 (−3.7;+2.6)
and −0.8 (−1.2;+0,7) to that without or with FCRD
(p > 0.05) and BMI/A medians (min; max) was −0.75
(−3,7;+2.6) and −0.41 (−1.0;+0.74) to adolescents with-
out or with FCDHR (p > 0.05), respectively. H/A means
(SD) was −0.83 (−3.8;1.2) and −1.38 (−2.2;-0.18) to adoles-
cents without or with FCDR (p > 0.05) and H/A means
was −0.75 (−3.7;+1.2) and −1.0 (−2.8;+0.9) to adolescents
without or with FCDHR, respectively (p > 0.05).
Considering all 30 adolescents, 73.3 % (22/30) were
taking nutritional supplement. BMI/A medians (min;
max), were 0.2 (−1.2;+2.6) and −0.72 (−3.7;+0.7) and
HAZ means were −0.4 (−3.3;1.2) and −1.0 (−3.7;+0,9) to
that adolescents without or taking nutritional supple-
ment, respectively (p > 0.05).
Among prepubertal, pubertal and postpubertal sub-
groups it were observed the medians (min;max) of Hb
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13.4 (11.9;14.7), 13.7 (11.7;15.6) and 13.6 (10.3;16.5); TP 7.1
(6.7;8.0), 6.8 (6.3;7.9) and 7.5 (6.1;7.8) and albumin 4.3
(3.9;4.7), 4.3 (3.6;4.6) and 4.1 (3.3;4.6); respectively (p > 0,05).
Table 2 presents the variables of the study according
to age, BMI/A and H/A. No significant difference in
mean age, BMI/A or H/A was observed between adoles-
cents with and without PI. Also, no significant difference
was observed regarding age at CF diagnosis or stages of
pubertal development.
The results observed in this study allow the discussion,
then, of some aspects. BMI/A has been recently adopted
as a parameter for the surveillance of nutritional status
in CF patients older than 2 years, and values above the
50th percentile are known to correlate with better pul-
monary function [7]. A BMI/A < 15th percentile (p15)
has been indicated as the ideal cut-off point for the def-
inition of malnutrition in CF patients and the Cystic
Fibrosis Foundation has recommended the BMI/A >
50th percentile as the goal to be reached for the nutri-
tional status of these individuals [8]. Although without
the rigor of the parameters adopted for consensus [9], in
the present study the adolescents showed a BMI/A
z-score of −0.6 (−3.7; 2.6) which corresponds to ad-
equate nutritional status according to the parameters
of the World Health Organization [6]. A study con-
ducted in Germany on CF patients aged 4 to 18 years
detected a BMI/A z-score of −0.1 [10].
The BMI/A z-score was similar for the present
adolescents with and without pancreatic insufficiency
(−0.7 and −0.8; respectively), whose nutritional status,
therefore, was of adequate level according to WHO
standards. These findings were close to those detected
in an Italian study on patients younger than 18 years
whose BMI/A z-scores were 0.2 and −0.3 for PS and PI,
respectively [11]. It should also be pointed out that all
the present adolescents with PI took pancreatic en-
zymes, which are extremely important for the mainten-
ance of nutritional status in such patients [12].
It is known that, the sooner the diagnosis of CF is
established, the more serious the symptoms and the
shorter the survival [13]. However, in the present study,
BMI/A z-scores did not differ significantly between an
early or late diagnosis of CF, being −0.8 and −0.5, re-
spectively. Although the present patients were not rou-
tinely genotyped, the results obtained agree with those
published by investigators from developed countries,
who reported that some patients with the classical mani-
festations of CF experience a mild disease course and
that, in addition, an important proportion of patents
with the severe and common delta F 508 mutation sur-
vive to 40 years of age with good maintenance of weight
and pulmonary function [14].
Also concerning the nutritional status, the present
group of prepubertal adolescents obtained the lowest
BMI/A z-score (−0.8). The pubertal and postpubertal ad-
olescents had z-scores of −0.2 and −0.7, respectively, all
of them being considered nutritionally adequate. Be-
cause in this phase of life complications such as hepatic
diseases, diabetes related to CF or even worsening of
pulmonary function may further aggravate the nutri-
tional status, more complications may have occurred in
the prepubertal group, since these factors were not con-
trolled due to the limited sample size [15, 16].
However, the better BMI/A z-scores detected in the
pubertal and postpubertal groups may have been due
not only to a satisfactory weight gain, but also to the
lack of a height gain adequate for age, since this
Table 1 Characteristics of the 30 adolescents evaluated at the












Use of pancreatic enzymes
Yes 21/30 70
No 9/30 30
Use of enzymes according
to pancreatic sufficiency
With pancreatic insufficiency 21/21 100
With pancreatic sufficiency 0/9 0
Age at CF diagnosis
<2 years 16/30 53.3
≥2 years 14/30 46.6
Age at diagnosis of
pancreatic insufficiency
<2 years 16/21 76.2
≥2 years 5/21 23.8
Pancreatic insufficiency in
patients diagnosed before
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indicator underestimates overweight and underdiag-
noses short stature in children and adolescents [17–19],
a fact that underscores the importance of evaluating
the H/A indicator.
The H/A ratio expresses linear growth and is consid-
ered to be the nutritional indicator that best points out
the cumulative effect of adverse situations and the most
sensitive one for the determination of quality of life in a
population [20]. A low H/A (<5th percentile) has been
recognized as a prognostic indicator of survival for CF
patients [21]. Among CF individuals, adolescence is a
period of high risk for delayed pubertal growth spurt
[22] and impaired final height [23, 24], which appears to
be mitigated by a better nutritional status at 7 years of
age [18].
The H/A z-score of −0.8 (−3.7; 1.2) detected in the
present patients is within adequate levels according to
WHO standards, without corresponding to a low H/A,
which characterizes worse survival among CF patients.
Similar results were obtained by Groeneweg et al. in
Germany [10].
No significant difference in H/A z-score was observed
between patients with and without PI, although the
borderline value of p = 0.05 may indicate impaired height
in PI patients compared to PS patients. Indeed, the nu-
tritional status of individuals with PS could be expected
to be better than that of individuals with PI, a result also
observed in a study conducted in Italy, in which signifi-
cant differences in z-score (p < 0.03) were detected be-
tween PS and PI subjects [11].
Regarding the different stages of adolescence, the H/A
z-scores did not differ significantly (p > 0.05) between
prepubertal (−0.7), pubertal (−1.5) and postpubertal
(−0.5) adolescents. Similarly H/A z-scores did not differ
significantly (p > 0.05) between the groups diagnosed
with CF before (−1.0) or after two years of age (−1.3).
The different stages of adolescence and the early or late
diagnosis of CF were not sufficient to differentiate the
Table 2 Distribution of the variables according to age, BMI/A and H/A of the 30 adolescents evaluated at the Reference Center of
Cystic Fibrosis of HC - FMRP - USP, 2010
Variables Median min; max p value
Age (years)
Pancreatic sufficiency Pancreatic Sufficient 14.2 10.77; 14.7 >0.05
Pancreatic Insufficient 14.5 10.1; 19.8
Pubertal stage Prepubertal 10.7 10.1; 14.7 >0.05
Pubertal 12.9 10.9; 19.0
Postpubertal 17.4 14.2; 19.8
Age at Cystic Fibrosis diagnosis <2 years 14.6 10.3; 19.8 >0.05
≥2 years 12.8 10.1; 19.4
BMI/Aa (z score)
Pancreatic Pancreatic Sufficient −0.8 −1.5; 1.7 >0.05
Sufficiency Pancreatic Insufficient −0.7 −3.7; 2.6
Pubertal stage Prepubertal −0.8 −3.7; 0.2 >0.5
Pubertal −0.2 −1.0; 2.6
Postpubertal −0.7 −2.4; 2.7
Age at Cystic Fibrosis diagnosis <2 years −0.8 −2.4; 1.7 >0.05
≥2 years −0.5 −3.7; 2.3
H/Ab (z score)
Pancreatic Pancreatic Sufficient −0.5 −2.9; 0.3 =0.05
Sufficiency Pancreatic Insufficient −0.8 −3.7; 1.3
Pubertal stage Prepubertal −0.7 −1.8; −0.2 >0.05
Pubertal −1.5 −3.3; 1.2
Postpubertal −0.5 3.7; 0.9
Age at Cystic Fibrosis diagnosis Before 2 years −1.1 −3.7; 0.3 >0.05
After 2 years −0.8 −3.3; 1.2
aBMI/A Body mass index of age
bH/A height for age
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nutritional status of the various adolescent subgroups
studied, with adequate H/A levels being observed in all
of them according to the WHO.
The pulmonary function between BMI/A subgroups
was not significant (p > 0.05), although 51.0 % adoles-
cents with thinness presented lower FEV1 median. In
turn, lower FEV1 means observed in 65.5 % adolescents
with low height revealed that pulmonary function be-
tween H/A subgroups was significant (p = 0.05). Other
researchers observed strong association between FEV1
and weight-for-height (ref. [25]).
The retrospective collection of anthropometric data is
one of the limitations of the present study, although
weight and height were measured by personnel trained
by specialists. Adequate means of Hb, PT and albumin,
corroborates the means of the anthropometric nutri-
tional indicators observed in this study. The absence of
genotyping and the non-exclusion of patients with major
complications such as liver disease and diabetes related
to CF are also limitations, which, however, did not over-
estimate the values observed.
Conclusions
Although the need for a more rigorous nutritional as-
sessment of individuals with CF is recognized, the ado-
lescents studied here showed adequate nutritional status
related to BMI/A and H/A, although with slightly lower
values than those of developed countries according to
WHO standards.
Parameters regarding an early or late diagnosis of CF
and the pubertal stage of these adolescents did not re-
veal differences in nutritional status when BMI/A or H/
A were considered.
BMI/A values did not differ in terms of status of pan-
creatic sufficiency, whereas H/A values were borderline
for the determination of height impairment in adoles-
cents with PI compared to adolescents without PI. FEV1
lower levels occurred more frequently in adolescents
with low H/A.
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